NSTE-ACS Guidelines Into Practice
This eModule course is designed to offer insight into the 2014 ACC/AHA Guidelines for the Management of Patients with Non-ST-Elevation – Acute Coronary Syndrome (NSTE-ACS).
View Activity Information

NSTE-ACS Guidelines Into Practice


Participation and Successful Completion
Successful completion of this CE activity includes the following: 

  1. Register and view the course online.
  2. View the content in its entirety.
  3. Complete a post-test with a minimum score of 75%.
  4. Complete a survey of your learning experience.
  5. Claim your CME/CE Certificate.

Hardware/Software Requirements
Internet Explorer 7 or greater, Firefox (Latest Version), Google Chrome, Windows 7 or above, Safari (Latest Version), Adobe Acrobat Reader, Internet Explorer is not supported on the Macintosh, Mac OS 10.4

Target Audience
Physicians -
Cardiology and others involved in the care of patients with heart failure



This eModule course is designed to offer insight into the 2014 ACC/AHA Guidelines for the Management of Patients with Non-ST-Elevation – Acute Coronary Syndrome (NSTE-ACS). 

  • Module 1: This module covers an overview of NSTE-ACS, the diagnosis of, and risk stratification for NSTE, and immediate management of NSTE-ACS
  • Module 2: This module covers evidence-based medical therapies and invasive therapies for NSTE-ACS patients
  • Module 3: This module covers providing effective late hospital care and implementing risk reduction strategies for NSTE-ACS patients
  • Module 4: This module covers handling special patient groups, and quality of NSTE-ACS care

Learning Objectives 
At the completion of this online course, the learner will be able to: 

  1. Explain the epidemiology, pathophysiology, and clinical presentation of NSTE-ACS
  2. Describe diagnostic dilemmas of NSTE-ACS.
  3. Explain the role of biomarkers in prognosis.
  4. Describe risk predictors and risk stratification models of NSTE-ACS.
  5. Describe AHA/ACC recommendations based on the Classification of Recommendations (COR) and Level of Evidence (LOE) parameters.
  6. Identify the immediate management of Non-ST Elevation Acute Coronary Syndromes (NSTE ACS).
  7. Apply the evidence-based medical therapy for patients with NSTE ACS.
  8. Identify patients with NSTE ACS who are appropriate candidates for invasive therapy.
  9. Identify the appropriate strategies for late hospital care and effective hospital discharge after NSTE ACS.
  10. Define secondary prevention strategies for patients with NSTE ACS.
  11. Identify the issues pertinent to special patient populations with NSTE ACS.
  12. Define the appropriate treatment strategy for the special patient groups based on the AHA/ACC guidelines.

Course Agenda



Module 1: Epidemiology, Pathophysiology, Diagnostic Dilemmas, and Risk Stratification

1 - 5

Module 2: Early Hospital Care

6 - 8

Module 3: Late Hospital Care

9 - 10

Module 4: Special Populations

11 - 12

Estimated Time to Complete the Educational Activity
90 minutes

Ezra Amsterdam, MD
Associate Chief of Academic Affairs
University of California Davis
Department of Internal Medicine 

Hani Jneid, MD
Associate Professor
Baylor College of Medicine 

Michele Pelter, RN, PhD
University of California San Francisco
School of Nursing 

Sarah Spinler, PharmD
University of Pennsylvania
Department of Medicine 

Marc Sabatine, MD
Harvard Medical School
Cardiovascular Medicine

Accreditation Statements



ACCREDITATION TERMS: Joint Accreditation – 03/05/2018 – 3/5/2021

In support of improving patient care, the American Heart Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AMA Credit Designation Statement - Physicians
The American Heart Association designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAPA Credit Acceptance Statement – Physician Assistants
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 1.50 hour of Category I credit for completing this program.

AANP Credit Acceptance Statement – Nurse Practitioners
American Academy of Nurse Practitioners (AANP) accepts AMA PRA Category 1 CreditTM from organizations accredited by the ACCME.

ANCC Credit Designation Statement - Nurses
The maximum number of hours awarded for this CE activity is 1.50 contact hour.

ACPE Credit Designation Statement – Pharmacists
ACPE Credit: 1.50 Contact Hour Universal Program Number: JA0000134-0000-18-011-H04-P

All persons who develop and/or control educational content in CME/CE activities provided by the American Heart Association will disclose to the audience all financial relationships with any commercial supporters of this activity as well as with other commercial interests whose lines of business are related to the CME/CE-certified content of this activity. In addition, presenters will disclose unlabeled/unapproved uses of drugs or devices discussed in their presentations. Such disclosures will be made in writing in course presentation materials.

Faculty Member


Research Grant

Advisory Board

Stock Shareholder (directly purchased)



Speaker’s Bureau

Ezra Amsterdam

University of California Davis


Astra Zeneca




Hani Jneid

Baylor College of Medicine






Michele Pelter

University of California San Francisco






Sarah Spinler

University of Pennsylvania




AstraZeneca, Boehringer Ingelheim, Daiichi Sankyo


Marc Sabatine

Harvard Medical School

Brigham and Women’s Hospital, Abbot Labs, Amgen, AstraZeneca, Critical Diagnostics, Daiichi-Sankyo, Elsai, Gilead, GlaxoSmithKline, Intarcia, Merck, Roche Diagnostics, Sanofi-Aventis, Takeda

Alnylam, Amgen, AstraZeneca, CVS Caremark, Intarcia, Merck




This table represents the relationships of this educational activity’s faculty members that may be perceived as actual or reasonable perceived conflicts of interest as reported on the Disclosure Questionnaire which all AHA volunteers are required to complete and submit. The focus is on relevant financial relationships with commercial interests in the 12-month period preceding the time that the individual is being asked to assume a role controlling content. 

This activity is an internet-based activity.

Contact Information
To contact the American Heart Association for any questions, please call our customer support center at 888-242-2453.

Policy on Privacy and Confidentiality
Please see the privacy link at the bottom of the Professional Education Center.

Copyright Information
Please see the link at the bottom of the Professional Education Center.

Commercial Support
This activity for professionals is part of the Guidelines Transformation & Optimization Program and is supported by an educational grant from AstraZeneca.  The American Heart Association’s Guideline Transformation & Optimization (GTO) Program is a comprehensive, coordinated approach to accelerate guidelines into clinical practice.

AstraZeneca is a proud inaugural sponsor of the American Heart Association’s Guideline Transformation & Optimization Initiative.

Type:  Internet Activity (Enduring Material)
Members Price
Non-members Price
75 Registered Users
1.5 Credits> Accreditation Council for Continuing Medical Education> AMA PRA Category 1 Credit

1.5 Contact Hours> Accreditation Council for Pharmacy Education> ACPE

0 Credits> American Heart Association> AHA

1.5 Contact Hours> American Nurses Credentialing Center> ANCC

1.5 Credits> Accreditation Council for Continuing Medical Education> Attendance Credit